Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 10 Colorectal Neoplasms 8 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 5 Neoplastic Cells, Circulating 4 Neoplasm Metastasis 4 Biliary Tract Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm, Residual 3 Disease 3 Squamous Cell Carcinoma of Head and Neck 2 Nevi and Melanomas 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Melanoma 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Sarcoma, Ewing 1

Interventions

Surveys and Questionnaires 114 Exercise 103 Blood Specimen Collection 99 Radiotherapy 67 Gemcitabine 64 Bevacizumab 57 Standard of Care 56 Cisplatin 55 Cyclophosphamide 51 Capecitabine 50 Carboplatin 49 Docetaxel 47 pembrolizumab 46 Dexamethasone 46 Paclitaxel 45 Interviews as Topic 43 Oxaliplatin 40 Magnetic Resonance Spectroscopy 39 Fluorouracil 37 Methods 36 Irinotecan 36 Therapeutics 33 Drug Therapy 33 Radiosurgery 31 Nivolumab 30 Erlotinib Hydrochloride 27 Educational Status 26 Everolimus 24 Leucovorin 23 Control Groups 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Liquid Biopsy × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡